BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25805398)

  • 1. Uterine carcinosarcoma: A review of the literature.
    Cantrell LA; Blank SV; Duska LR
    Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
    Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine carcinosarcomas: From pathology to practice.
    Toboni MD; Crane EK; Brown J; Shushkevich A; Chiang S; Slomovitz BM; Levine DA; Dowdy SC; Klopp A; Powell MA; Thaker PH
    Gynecol Oncol; 2021 Jul; 162(1):235-241. PubMed ID: 34030871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare uterine cancer: carcinosarcomas. Review from histology to treatment.
    Artioli G; Wabersich J; Ludwig K; Gardiman MP; Borgato L; Garbin F
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):98-104. PubMed ID: 25468677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma.
    Elshaikh MA; Modh A; Jhingran A; Biagioli MC; Coleman RL; Gaffney DK; Harkenrider MM; Heskett K; Jolly S; Kidd E; Lee LJ; Li L; Portelance L; Sherertz T; Venkatessan AM; Wahl AO; Yashar CM; Small W
    Gynecol Oncol; 2020 Aug; 158(2):460-466. PubMed ID: 32475772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular classification and subtype-specific drug sensitivity research of uterine carcinosarcoma under multi-omics framework.
    Lu X; Zhang L; Zhao H; Chen C; Wang Y; Liu S; Lin X; Wang Y; Zhang Q; Lu T; Yan F
    Cancer Biol Ther; 2019; 20(2):227-235. PubMed ID: 30359167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
    Hensley ML
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is minimally invasive surgery for clinical stage I uterine carcinosarcoma safe?
    Sinha R; Nizam A; Shan W; Shih KK; Frimer M; Sakaris A; Goldberg GL
    J Robot Surg; 2022 Aug; 16(4):943-949. PubMed ID: 34716874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous cancer: a review of the literature.
    del Carmen MG; Birrer M; Schorge JO
    Gynecol Oncol; 2012 Dec; 127(3):651-61. PubMed ID: 23000148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: a case report.
    Kahraman K; Ortac F; Kankaya D; Aynaoglu G
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):89-92. PubMed ID: 22482976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic features of surgical stage I uterine carcinosarcoma.
    Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
    Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
    Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
    Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uterine carcinosarcoma].
    Serkies K; Jassem J
    Ginekol Pol; 2012 Aug; 83(8):609-12. PubMed ID: 23342885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Adjuvant Pelvic Radiotherapy on Distant Metastasis for Uterine Carcinosarcoma.
    Eng NL; Rana SR; Hall KL; Eng TY
    Am J Clin Oncol; 2021 Apr; 44(4):169-173. PubMed ID: 33481373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.